Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Samsung’s US$400,000 bonus fuels labour disputes across South Korea

    TenPay Global Named To CNBC’s World’s Top Fintech Companies 2026 List

    2026 NASCAR Odds: Shane van Gisbergen Heavy Favorite For San Diego Street Course

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest VKontakte
    Sg Latest NewsSg Latest News
    • Home
    • Politics
    • Business
    • Technology
    • Entertainment
    • Health
    • Sports
    Sg Latest NewsSg Latest News
    Home»Health»Oppenheimer Appoints James Yoo Managing Director in Healthcare Equity Capital Markets Investment Banking
    Health

    Oppenheimer Appoints James Yoo Managing Director in Healthcare Equity Capital Markets Investment Banking

    AdminBy AdminNo Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Seasoned industry professional brings 27 years of experience to expanding Healthcare platform

    NEW YORK, Oct. 6, 2025 /PRNewswire/ — Oppenheimer & Co. Inc. (“Oppenheimer”) — a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — today announced that James Yoo has been named a Managing Director within its Healthcare Equity Capital Markets Investment Banking Group. In this role, Mr. Yoo will focus on Biotechnology Equity Capital Markets transactions.

    With 27 years of experience, Mr. Yoo has developed deep expertise in a range of financing structures, including Private Investment in Public Equity (PIPEs), Follow-on Offerings, Confidentially Marketed Public Offerings (CMPOs) and Registered Direct transactions.

    “James brings an exceptional track record of execution and deep relationships across the biotechnology investment community to his new role,” said Peter Bennett, Managing Director and Head of Equity Capital Markets Investment Banking at Oppenheimer. “His ability to navigate complex financing structures will further strengthen Oppenheimer’s leadership in Healthcare Equity Capital Markets.”

    Before stepping into his new role, Mr. Yoo served as the Healthcare Specialist on Oppenheimer’s Sales & Trading Desk since 2023, advising healthcare-dedicated investment funds and early- and late-stage biotechnology companies. Prior to Oppenheimer, he held various positions at leading firms such as Piper Sandler, Mizuho, and Nomura.

    “I am honored to join Oppenheimer’s Healthcare Equity Capital Markets Investment Banking Group at such an exciting time for the biotechnology sector,” Yoo said. “The firm’s collaborative culture and broad platform create an exceptional environment to deliver innovative capital markets solutions. I look forward to working with my colleagues to help biotech companies access the financing they need to advance groundbreaking science and improve patient outcomes.”

    About Oppenheimer Holdings Inc.
    Oppenheimer Holdings Inc., through its Oppenheimer & Co. Inc. subsidiary, and related entities, provides a full range of wealth management, securities brokerage, and investment banking services to high-net-worth individuals, families, corporate executives, businesses, and institutions. For more information, please visit www.oppenheimer.com.

    Media Contact:
    Joseph Kuo / Michael Dugan
    Haven Tower Group LLC
    424 317 4851 or 424 317 4852
    [email protected] or [email protected]

    SOURCE Oppenheimer & Co. Inc.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Admin
    • Website

    Related Posts

    Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy

    FDA reviews peptide injections favored by RFK Jr. and wellness influencers

    What parents should know about the infant botulism outbreak caused by baby formula

    GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB

    Add A Comment
    Leave A Reply Cancel Reply

    Editors Picks

    Most Impressive Team Streaks Of The 21st Century: Where Does 2024-26 Spain Rank?

    NBC’s ‘Stumble’ is a mockumentary about a cheer team with plenty of tumbling runs and heart

    Xiaomi shares post worst week in 3½ years as accidents stoke EV safety concerns

    Judge reverses Trump administration’s cuts of billions of dollars to Harvard University

    Top Reviews
    9.1

    Review: Mi 10 Mobile with Qualcomm Snapdragon 870 Mobile Platform

    By Admin
    8.9

    Comparison of Mobile Phone Providers: 4G Connectivity & Speed

    By Admin
    8.9

    Which LED Lights for Nail Salon Safe? Comparison of Major Brands

    By Admin
    Sg Latest News
    Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
    • Get In Touch
    © 2026 SglatestNews. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.